International Clinical Trial: Third-Generation TKI with or without Radiotherapy for Advanced EGFR-Mutant NSCLC?

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132219) titled 'Third-Generation TKI with or without Radiotherapy for Advanced EGFR-Mutant NSCLC?' on Sept. 10.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: The Second Affiliated Hospital of Hainan Medical University

Condition: Non Small Lung Cancer

Intervention: Third-Generation EGFR-TKI Combined with Thoracic Radiotherapy:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-07

Target Sample Size: Third-Generation EGFR-TKI Combined with Thoracic Radiotherapy:30;Third-Generation TKI Monotherapy Group:30;

Countries of Recruitment: China

To know more,...